Author:
Alloway R.,Steinberg S.,Khalil K.,Gourishankar S.,Miller J.,Norman D.,Hariharan S.,Pirsch J.,Matas A.,Zaltzman J.,Wisemandle K.,Fitzsimmons W.,First M.R.
Reference6 articles.
1. New drugs to improve transplant outcomes;First;Transplantation,2004
2. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants;Didlake;Transplant Proc,1998
3. Frequency and impact of nonadherence to immunosuppressants after transplantation: a systematic review;Butler;Transplantation,2004
4. A comparison of the two-sided tests procedure and the power approach for assessing the equivalence of average bioavailability;Schuirmann;J Pharmacokin Biopharm,1987
5. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); July 2002.
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献